Scottish Translational Medicine and Therapeutics Initiative (STMTI)

The Scottish Translational Medicine and Therapeutics Initiative (STMTI) is a novel collaboration between the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, funded by the Wellcome Trust with additional support from Pfizer Pharmaceuticals. It’s objective is to create a new cadre of academic clinicians with expertise in translational medicine and therapeutics through its PhD programme. Opportunities are available to undertake the first module of a Masters in Translational Medicine (Certificate Level) as part of this Initiative.

Further information is available from the Scottish Translational Medicine and Therapeutics Initiative website.


Accessibility menu